LGVN
Price
$1.18
Change
-$0.01 (-0.84%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
17.71M
SNGX
Price
$1.84
Change
-$0.06 (-3.16%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
6.01M
Interact to see
Advertisement

LGVN vs SNGX

Header iconLGVN vs SNGX Comparison
Open Charts LGVN vs SNGXBanner chart's image
Longeveron
Price$1.18
Change-$0.01 (-0.84%)
Volume$426
Capitalization17.71M
Soligenix
Price$1.84
Change-$0.06 (-3.16%)
Volume$183
Capitalization6.01M
LGVN vs SNGX Comparison Chart
Loading...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGVN vs. SNGX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGVN is a Hold and SNGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (LGVN: $1.18 vs. SNGX: $1.84)
Brand notoriety: LGVN and SNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGVN: 54% vs. SNGX: 28%
Market capitalization -- LGVN: $17.71M vs. SNGX: $6.01M
LGVN [@Biotechnology] is valued at $17.71M. SNGX’s [@Biotechnology] market capitalization is $6.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGVN’s FA Score shows that 1 FA rating(s) are green whileSNGX’s FA Score has 1 green FA rating(s).

  • LGVN’s FA Score: 1 green, 4 red.
  • SNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, both LGVN and SNGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGVN’s TA Score shows that 4 TA indicator(s) are bullish while SNGX’s TA Score has 3 bullish TA indicator(s).

  • LGVN’s TA Score: 4 bullish, 6 bearish.
  • SNGX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, SNGX is a better buy in the short-term than LGVN.

Price Growth

LGVN (@Biotechnology) experienced а -9.92% price change this week, while SNGX (@Biotechnology) price change was -4.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

LGVN is expected to report earnings on May 08, 2025.

SNGX is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGVN($17.7M) has a higher market cap than SNGX($6.01M). SNGX YTD gains are higher at: -29.499 vs. LGVN (-31.214). SNGX has higher annual earnings (EBITDA): -8.06M vs. LGVN (-15.56M). LGVN has more cash in the bank: 19.2M vs. SNGX (9.84M). LGVN has less debt than SNGX: LGVN (1.45M) vs SNGX (2.2M). LGVN has higher revenues than SNGX: LGVN (2.39M) vs SNGX (0).
LGVNSNGXLGVN / SNGX
Capitalization17.7M6.01M295%
EBITDA-15.56M-8.06M193%
Gain YTD-31.214-29.499106%
P/E RatioN/AN/A-
Revenue2.39M0-
Total Cash19.2M9.84M195%
Total Debt1.45M2.2M66%
FUNDAMENTALS RATINGS
SNGX: Fundamental Ratings
SNGX
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LGVNSNGX
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 21 days ago
82%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNSP1.060.05
+4.95%
CNS Pharmaceuticals Inc.
KMX65.91-0.34
-0.51%
CarMax
ABM52.33-0.39
-0.74%
ABM Industries
OPBK11.94-0.11
-0.91%
OP Bancorp
HTLD8.81-0.19
-2.11%
Heartland Express

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with RNA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
+0.85%
RNA - LGVN
36%
Loosely correlated
-0.55%
SRPT - LGVN
34%
Loosely correlated
+1.72%
ENTA - LGVN
34%
Loosely correlated
-1.11%
FATE - LGVN
33%
Loosely correlated
+4.41%
AXON - LGVN
30%
Poorly correlated
+2.76%
More

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been loosely correlated with THAR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNGX jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
-2.56%
THAR - SNGX
46%
Loosely correlated
+1.02%
VRAX - SNGX
36%
Loosely correlated
-5.00%
QURE - SNGX
36%
Loosely correlated
-1.32%
ATHA - SNGX
31%
Poorly correlated
+9.16%
LGVN - SNGX
30%
Poorly correlated
+0.85%
More